Physician profile
Mona Sadek
NPI 1275500746
$1,849.96
in general payments reported to CMS, 2019-2025
23 companies · $23.09 in 2025
The $23.09 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $351 · 2020: $21.21 · 2021: $121 · 2022: $446 · 2023: $573 · 2024: $315 · 2025: $23.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.86 |
| Education | $136.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $348.13 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $265.24 | 2019-2024 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $199.43 | 2022-2024 | Nuvessa, Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $195.87 | 2019-2023 | |
| Organon LLC | $97.42 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $92.14 | 2023-2024 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $87.37 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $78.73 | 2022-2023 | |
| Pfizer INC. | $72.17 | 2019-2023 | |
| Minerva Surgical, INC | $57.39 | 2022-2025 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Amgen INC. | $48.05 | 2023-2024 | Prolia, Evenity |
| Convatec INC. | $43.30 | 2019 | |
| Amag Pharmaceuticals, INC. | $33.98 | 2019 | |
| Merck Sharp & Dohme LLC | $32.87 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $24.31 | 2024 | |
| Shield Therapeutics INC | $21.34 | 2023 | Accrufer |
| Avion Pharmaceuticals | $19.64 | 2022 | |
| Myovant Sciences INC. | $18.45 | 2022 | |
| Aspira Women'S Health INC | $16.19 | 2023 | Ova1 |
| Abbott Laboratories | $15.13 | 2023 | Proclaim |
| Evofem Biosciences, INC. | $13.48 | 2021 | |
| Mycovia Pharmaceuticals, INC. | $13.15 | 2023 | Vivjoa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mona Sadek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.